Relationship of comorbidity to the severity of the course of the novel coronavirus infection in patients who have delivered in a District Clinical Hospital of Khanty-Mansiysk

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To study the structure of somatic morbidity and comorbidity in pregnant women living in the Khanty-Mansi Autonomous Area and to evaluate its impact on the severity of the course of novel coronavirus infection (NCI) and the outcomes of pregnancy.

Subjects and methods. A single-center prospective comparative study was conducted in the groups of women who experienced NCI in the third trimester from March 2020 to April 2022 (n=149). The patients were divided into groups: 1) mild NCI (without pneumonia) (n=78); 2) moderate NCI (n=52); 3) severe NCI (n=19).

Results. A statistically significant relationship was found between the presence of obesity concurrent with diseases of the urinary system, the upper respiratory tract, and severe NCI (p=0.04). Chronic pyelonephritis in the patients’ history was statistically significantly associated with oligohydramnios (p<0.001) and gestational diabetes mellitus (GDM) (95% confidence interval, 1.070–8.883).

Conclusion. Ninety (60.4%) pregnant women who had experienced NCI were found to have a history of somatic diseases; the comorbidity index was 1.9. The concurrence of endocrine and urinary diseases with chronic upper respiratory tract ones significantly worsened the course of NCI and led to placental disorders and GDM.

Full Text

Restricted Access

About the authors

E. E. Chernaya

Khanty-Mansiysk State Medical Academy

Author for correspondence.
Email: chyornayaekaterina@yandex.ru
ORCID iD: 0000-0002-9899-3279

Candidate of Medical Sciences

Russian Federation, Khanty-Mansiysk

A. E. Kasparova

Khanty-Mansiysk State Medical Academy; District Clinical Hospital

Email: chyornayaekaterina@yandex.ru
ORCID iD: 0000-0001-7665-2249

MD, Associate Professor

Russian Federation, Khanty-Mansiysk; Khanty-Mansiysk

V. L. Yanin

Khanty-Mansiysk State Medical Academy

Email: chyornayaekaterina@yandex.ru
ORCID iD: 0000-0001-5723-1246

MD, Professor

Russian Federation, Khanty-Mansiysk

E. I. Kutefa

District Clinical Hospital

Email: chyornayaekaterina@yandex.ru
ORCID iD: 0000-0003-2946-0249
Russian Federation, Khanty-Mansiysk

E. N. Vasilkovskaya

Khanty-Mansiysk State Medical Academy; District Clinical Hospital

Email: chyornayaekaterina@yandex.ru
ORCID iD: 0000-0003-1586-0532
Russian Federation, Khanty-Mansiysk; Khanty-Mansiysk

L. A. Chegus

Khanty-Mansiysk State Medical Academy; District Clinical Hospital

Email: chyornayaekaterina@yandex.ru
ORCID iD: 0000-0002-9698-8038

Candidate of Medical Sciences, Associate Professor

Russian Federation, Khanty-Mansiysk; Khanty-Mansiysk

S. I. Semenchenko

Khanty-Mansiysk State Medical Academy; District Clinical Hospital

Email: chyornayaekaterina@yandex.ru
ORCID iD: 0000-0003-1157-6753

Candidate of Medical Sciences, Associate Professor

Russian Federation, Khanty-Mansiysk; Khanty-Mansiysk

F. R. Hidirnebieva

Khanty-Mansiysk State Medical Academy

Email: chyornayaekaterina@yandex.ru
ORCID iD: 0000-0002-7356-6115
Russian Federation, Khanty-Mansiysk

References

  1. Туманова У.Н., Щеголев А.И., Чаусов А.А. и др. Анализ причин ранней неонатальной смертности в Российской Федерации в 2020 г. (год пандемии COVID-19). Вестник РГМУ. 2021; 5: 76–83 [Tumanova U.N., Shchegolev A.I., Chausov A.A. et al. Analysis of causes of early neonatal mortality during Covid-19 pandemic in 2020 in Russia. Bulletin of Russian State Medical University. 2021; 5: 76–83 (in Russ.)]. doi: 10.24075/vrgmu.2021.045
  2. Мальгина Г.Б., Дьякова М.М., Бычкова С.В. и др. Особенности клинических проявлений легких и среднетяжелых форм новой коронавирусной инфекции у беременных в динамике эпидемического процесса. Акушерство и гинекология. 2022; 3: 23–31 [Malgina G.B., Dyakova M.M., Bychkova S.V. et al. Clinical manifestations of mild and moderate novel coronavirus disease in pregnant women in epidemic dynamics. Obstetrics and Gynecology. 2022; 3: 23–31 (in Russ.)]. doi: 10.18565/aig.2022.3.23-31
  3. Bousquet J., Zuberbier T., Cristol J.-P. et al. NRF2-interacting nutrients and COVID-19: time for research to develop adaptation strategies. Clin Transl Allergy. 2020; 10 (1): 58. doi: 10.1186/s13601-020-00362-7
  4. Дедов Д.В. Новая коронавирусная инфекция: клинико-патогенетические аспекты, профилактика, значение витаминов и микроэлементов. Врач. 2022; 33 (2): 47–9 [Dedov D. New coronavirus infection: clinical and pathogenetic aspects, prevention, importance of vitamins and trace elements. Vrach. 2022; 33 (2): 47–9 (in Russ.)] doi: 10.29296/25877305-2022-02-07
  5. Каспарова А.Э., Кутефа Е.И., Васильковская Е.Н. и др. Осложнения гестации и особенности течения родов у беременных с новой коронавирусной инфекцией, родоразрешенных в окружной клинической больнице города Ханты-Мансийска. Ульяновский медико-биологический журнал. 2022; 4: 74–92 [Kasparova A.E., Kutefa E.I., Vasil'kovskaya E.N. et al. Pregnancy complications and mode of delivery in COVID-19 women performing delivery in the district clinical hospital in Khanty-Mansiysk. Ulyanovsk Medico-biological Journal. 2022; 4: 74–92 (in Russ.)]. doi: 10.34014/2227-1848-2022-4-74-92
  6. Bramham K., Parnell B., Nelson-Piercy C. et al. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014; 348: g2301. doi: 10.1136/bmj.g2301
  7. Филиппов О.С., Гусева Е.В. Материнская смертность в Российской Федерации в 2020 году: первый год пандемии COVID-19. Проблемы репродукции. 2022; 28 (1): 8–28 [Filippov O.S., Guseva E.V. Maternal mortality in the Russian Federation in 2020: the first year of the pandemic. Russian Journal of Human Reproduction. 2022; 28 (1): 8–28 (in Russ.)]. doi: 10.17116/repro2022280118
  8. Galang R.R., Newton S.M., Woodworth K.R. et al. Centers for Disease Control and Prevention COVID-19 Response Pregnancy and Infant Linked Outcomes Team. Risk Factors for Illness Severity Among Pregnant Women With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Infection-Surveillance for Emerging Threats to Mothers and Babies Network, 22 State, Local, and Territorial Health Departments, 29 March 2020-5 March 2021. Clin Infect Dis. 2021; 73 (Suppl 1): S17–S23. doi: 10.1093/cid/ciab432
  9. Молочков А.В., Каратеев Д.Е., Огнева Е.Ю. и др. Коморбидные заболевания и прогнозирование исхода COVID-19: результаты наблюдения 13 585 больных, находившихся на стационарном лечении в больницах Московской области. Альманах клинической медицины. 2020; 48 (S1): S1–10 [Molochkov A.V., Karateev D.E., Ogneva E.Yu. et al. Comorbidities and predicting the outcome of COVID-19: the treatment results of 13,585 patients hospitalized in the Moscow Region. Almanac of Clinical Medicine. 2020; 48 (S1): S1–10 (in Russ.)]. doi: 10.18786/2072-0505-2020-48-040
  10. Wang S., Ma P., Zhang S. et al. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia. 2020; 63 (10): 2102–11. doi: 10.1007/s00125-020-05209-1
  11. Радзинский В.Е. и др. Очерки эндокринной гинекологии. М.: Редакция журнала StatusPraesens, 2020; с. 567 [Radzinskii V.E. et al. Ocherki endokrinnoi ginekologii. M.: Redaktsiya zhurnala StatusPraesens, 2020; р. 567 (in Russ.)].
  12. Paredes C., Hsu R.C., Tong A. et al. Obesity and Pregnancy. Neoreviews. 2021; 22 (2): e78–e87. doi: 10.1542/neo.22-2-e78
  13. Kapustin R., Chepanov S., Kopteeva E. et al. Maternal serumnitrotyrosine, 8-isoprostane andtotalanti oxidantcapacitylevelsinpre-gestationalorgestationaldiabetesmellitus. Gynecol Endocrinol. 2020; 36 (sup1): 36–42. doi: 10.1080/09513590.2020.1816727
  14. Mackin S.T., Nelson S.M., Wild S.H. et al. SDRN Epidemiology Group and Scottish Diabetes Group Pregnancy subgroup. Factors associated with stillbirth in women with diabetes. Diabetologia. 2019; 62 (10): 1938–47. doi: 10.1007/s00125-019-4943-9
  15. Flenady V., Koopmans L., Middleton P. et al. Major risk factors for still birth in high-income countries: a systematic review and meta-analysis. Lancet. 2011; 377 (9774): 1331–40. doi: 10.1016/S0140-6736(10)62233-7
  16. Liu L., Wang H., Zhang Y. et al. Effect of pregravid obesity on perinatal outcomes in singleton pregnancies following in vitro fertilization and the weight-loss goals to reduce the risks of poor pregnancy outcomes: A retrospective cohort study. PLoS One. 2020; 15 (2): e0227766. doi: 10.1371/journal.pone.0227766
  17. Kayem G., Lecarpentier E., Deruelle P. et al. A snap shot of the Covid-19 pandemic among pregnant women in France. J Gynecol Obstet Hum Reprod. 2020; 49 (7): 101826. doi: 10.1016/j.jogoh.2020.101826
  18. Nalbandian A., Sehgal K., Gupta A. et al. Post-acute COVID-19 syndrome. Nat Med. 2021; 27 (4): 601–15. doi: 10.1038/s41591-021-01283-z
  19. Lania A., Sandri M.T., Cellini M. et al. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020; 183 (4): 381–7. doi: 10.1530/EJE-20-0335
  20. Adu-Gyamfi E.A., Wang Y.X., Ding Y.B. The interplay between thyroid hormones and the placenta: a comprehensive review. Biol Reprod. 2020; 102 (1): 8–17. doi: 10.1093/biolre/ioz182
  21. Brancatella A., Ricci D., Viola N. et al. Subacute Thyroiditis After Sars-COV-2 Infection. J Clin Endocrinol Metab. 2020; 105 (7): dgaa276. doi: 10.1210/clinem/dgaa276
  22. Al Khalaf S., Bodunde E., Maher G.M. et al. Chronic kidney disease and adverse pregnancy outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022; 226 (5): 656–670.e32. doi: 10.1016/j.ajog.2021.10.037
  23. Макацария А.Д., Слуханчук Е.В., Бицадзе В.О. и др. Тромботический шторм, нарушения гемостаза и тромбовоспаление в условиях COVID-19. Акушерство, Гинекология, Репродукция. 2021; 15 (5): 499–514 [Makatsariya A.D., Slukhanchuk E.V., Bitsadze V.O. et al. Thrombotic storm, hemostasis disorders and thromboinflammation in COVID-19. Obstetrics, Gynecology and Reproduction. 2021; 15 (5): 499–514 (in Russ.)]. doi: 10.17749/2313-7347/ob.gyn.rep.2021.247
  24. Черная Е.Е. Особенности некоторых метаболических и морфологических реакций гестационной адаптации пришлых жительниц Субарктическго региона. Вестник СурГУ. Медицина. 2017; 4: 49–57 [Chyornaya E.E. Peculiarities of some metabolic and morphological reactions of gestational adaptation of alien population of the Subarctic region. Vestnik SurGU. Meditsina. 2017; 4: 49–57 (in Russ.)].
  25. Радзинский В.Е. и др. Предиктивное акушерство. М.: Редакция журнала StatusPraesens, 2021; с. 520 [Radzinskii V.E. et al. Prediktivnoe akusherstvo. M.: Redaktsiya zhurnala StatusPraesens, 2021; р. 520 (in Russ.)].
  26. Jafari M., Pormohammad A., Sheikh Neshin S.A. et al. Clinical characteris tics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis. Rev Med Virol. 2021; 31 (5): 1–16. doi: 10.1002/rmv.2208
  27. Salvatore M.A., Corsi Decenti E., Bonasoni M.P. et al, The ItOSS Covid-Working Group. Placental Characteristics of a Large Italian Cohort of SARS-CoV-2-Positive Pregnant Women. Microorganisms. 2022; 10 (7): 1435. doi: 10.3390/microorganisms10071435
  28. Deemah Salem, Fawzi Katranji, Talah Bakdash. COVID-19 infection in pregnant women: Review of maternal and fetal outcomes. Int J Gynaecol Obstet. 2021; 152 (3): 291–8. doi: 10.1002/ijgo.13533
  29. Kim H.K., Kim H., Kyu M. Lee et al. et al. Generation of tonsil organoids as an ex vivo model for SARS-CoV-2 infection. bioRxiv. 2020. doi: 10.1101/2020.08.06.239574
  30. Hosier H., Farhadian S.F., Morotti R.A. et al. SARS-CoV-2 infection of the placenta. J Clin Invest. 2020; 130 (9): 4947–53. doi: 10.1172/JCI139569
  31. Chen H., Guo J., Wang C. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020; 395 (10226): 809–15 [Erratum in: Lancet. 2020; 395 (10229): 1038]. doi: 10.1016/S0140-6736(20)30360-3
  32. Suhren J.T., Meinardus A., Hussein K. et al. Meta-analysison COVID-19-pregnancy-related placental pathologies shows no specific pattern. Placenta. 2022; 117: 72–7. doi: 10.1016/j.placenta.2021.10.010
  33. Патологическая анатомия COVID-19. Под ред. О.В. Зайратьянца. М.: ГБУ «НИИОЗММ ДЗМ», 2020; 140 с. [Patologicheskaya anatomiya COVID-19. Pod red. O.V. Zairat'yantsa. M.: GBU «NIIOZMM DZM», 2020; 140 р. (in Russ.)].

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. The severity of NCI according to the experienced endocrine diseases

Download (134KB)
3. Fig. 2. Hospital stay length in women with experienced NCI and their newborns

Download (144KB)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies